Regulation (EU) 2019/5

E555035

Regulation (EU) 2019/5 is an EU legislative act that updates and supplements the legal framework governing the European Medicines Agency and the authorization and supervision of medicinal products within the European Union.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (1)

Label Occurrences
Regulation (EU) 2019/5 canonical 1

Statements (46)

Predicate Object
instanceOf European Union regulation
adoptedBy Council of the European Union NERFINISHED
European Parliament NERFINISHED
aimsTo improve functioning of the internal market for medicinal products
streamline procedures for authorisation of medicinal products
strengthen supervision of medicinal products
update the legal framework for the European Medicines Agency
amends Directive 2001/83/EC NERFINISHED
Regulation (EC) No 141/2000 NERFINISHED
Regulation (EC) No 1901/2006 NERFINISHED
Regulation (EC) No 726/2004 NERFINISHED
appliesTo European Economic Area NERFINISHED
basedOn Treaty on the Functioning of the European Union NERFINISHED
bindingInItsEntirety true
concerns European Medicines Agency governance
centralised marketing authorisation procedure
post-authorisation safety monitoring
regulatory procedures for medicinal products
directlyApplicableInMemberStates true
hasLegalEffectIn all EU Member States
jurisdiction European Union
languageVersions all official EU languages
legalForm regulation
partOf EU pharmaceutical legislation
policyArea health and consumer protection
internal market
regulates coordination between EMA and national authorities
data and information exchange on medicinal products
obligations of marketing authorisation holders
procedures for evaluation of medicinal products
relatedInstrument Regulation (EU) 2019/6 NERFINISHED
relatedTo EU medicines regulatory network NERFINISHED
marketing authorisation holders
requiresComplianceFrom marketing authorisation applicants
pharmaceutical companies
requiresImplementationBy EU Member States competent authorities
European Medicines Agency NERFINISHED
sector pharmaceuticals
public health
subjectMatter European Medicines Agency NERFINISHED
authorization of medicinal products
human medicinal products
pharmacovigilance
supervision of medicinal products
veterinary medicinal products
typeOfAct co-decision act

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.